NDC 0085-2224

NOXAFIL

Posaconazole

NOXAFIL is a Oral Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Posaconazole.

Product ID0085-2224_4074d802-2e64-450e-aa7f-217b011d8324
NDC0085-2224
Product TypeHuman Prescription Drug
Proprietary NameNOXAFIL
Generic NamePosaconazole
Dosage FormPowder, For Suspension
Route of AdministrationORAL
Marketing Start Date2021-06-08
Marketing CategoryNDA /
Application NumberNDA214770
Labeler NameMerck Sharp & Dohme Corp.
Substance NamePOSACONAZOLE
Active Ingredient Strength300 mg/1
Pharm ClassesAzole Antifungal [EPC],Azoles [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0085-2224-02

8 PACKET in 1 CARTON (0085-2224-02) > 1 POWDER, FOR SUSPENSION in 1 PACKET (0085-2224-01)
Marketing Start Date2021-06-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "NOXAFIL" or generic name "Posaconazole"

NDCBrand NameGeneric Name
0085-1328NOXAFILposaconazole
0085-2224NOXAFILposaconazole
0085-4324NOXAFILposaconazole
0085-4331NOXAFILposaconazole
0254-2045POSACONAZOLEposaconazole
0406-7711POSACONAZOLEposaconazole
0527-2133POSACONAZOLEPosaconazole

Trademark Results [NOXAFIL]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NOXAFIL
NOXAFIL
77007334 3825429 Live/Registered
MERCK SHARP & DOHME CORP.
2006-09-25
NOXAFIL
NOXAFIL
75731165 2468349 Live/Registered
MERCK SHARP & DOHME CORP.
1999-06-17
NOXAFIL
NOXAFIL
75217327 not registered Dead/Abandoned
SCHERING CORPORATION
1996-12-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.